(Q37879448)

24 August 2017

1 reference

title

A comprehensive review of the clinical aspects of primary aldosteronism (English)

1 reference

24 August 2017

Gian Paolo Rossi

1

1 reference

24 August 2017

publication date

24 May 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

485-495

1 reference

Aldosterone: a risk factor for vascular disease

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Myocardial collagen matrix remodelling in arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Left ventricular systolic function in primary aldosteronism and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Relations between cardiac and vascular structure in patients with primary and secondary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Renal damage in primary aldosteronism: results of the PAPY Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary aldosteronism: cardiovascular, renal and metabolic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Surgically correctable hypertension caused by primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary aldosteronism: an update on screening, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Hyperaldosteronism among black and white subjects with resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

The aldosterone–renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Plasma renin and aldosterone measurements in low renin hypertensive states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Diagnosis and management of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Captopril suppression versus salt loading in confirming primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Diagnostic value of the post-captopril test in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Role for adrenal venous sampling in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Adrenal vein sampling: how to make it quick, easy, and successful

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

What we still do not know about adrenal vein sampling for primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Comparison of sequential versus simultaneous methods of adrenal venous sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Adrenocortical zonation in humans under normal and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Remodeling of the rat right and left ventricles in experimental hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Long-term renal outcomes in patients with primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Cardiovascular complications in patients with primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

31 March 2020

A concluding response

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

High incidence of primary aldosteronism in 199 patients referred with hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Screening for primary aldosteronism with a logistic multivariate discriminant analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Further evaluation of saline infusion for the diagnosis of primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

31 March 2020

Primary aldosteronism

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

A thoracic mass with hypertension and hypokalaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Comparison of confirmatory tests for the diagnosis of primary aldosteronism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Suppression of Renin and Aldosterone by Small Amounts of DOCA in Normal Man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.76

Plasma renin activity and plasma prorenin assays.

31 March 2020

1 reference

12 December 2020

Albuminuria in untreated patients with primary aldosteronism or essential hypertension

1 reference

12 December 2020

Laparoscopic versus open adrenalectomy: outcome in 35 consecutive patients.

1 reference

12 December 2020

The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism

1 reference

12 December 2020

Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases

1 reference

12 December 2020

Re: to stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not? Round 2

1 reference

12 December 2020

Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension

1 reference

12 December 2020

Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature.

1 reference

12 December 2020

Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.

1 reference

12 December 2020

PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION

1 reference

12 December 2020

Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome, 1954.

1 reference

12 December 2020

A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

1 reference

12 December 2020

Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups.

1 reference

12 December 2020

Incidentally discovered adrenal masses

1 reference

12 December 2020

Plasma renin activity: temperature optimum at approximately 45 degrees C

1 reference

12 December 2020

[Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach]

1 reference

12 December 2020

Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore

1 reference

12 December 2020

Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism

1 reference

12 December 2020

The aldosterone/renin ratio as a screening test for primary aldosteronism

1 reference

12 December 2020

[High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]

1 reference

12 December 2020

Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism

1 reference

12 December 2020

[What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?]

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.76

1 reference

24 August 2017

1 reference